Depression, cardiometabolic function and left ventricular hypertrophy in African men and women: the SABPA study

Nyiko Mashele1, Leoné Malan, Johannes M van Rooyen

  • 1Hypertension in Africa Research Team (HART), School for Physiology, Nutrition and Consumer Sciences, North-West University, Potchefstroom, South Africa.

Insights

Depression is linked to heart disease risk in African populations. In women, depressive symptoms and metabolic factors contribute to left ventricular hypertrophy (LVH). In men, cardiometabolic factors drive LVH, regardless of depression.

Area of Science:

  • Cardiology
  • Psychiatry
  • Metabolic Syndrome Research

Background:

  • Depressive symptoms increase cardiovascular disease risk, often linked to metabolic syndrome (MetS).
  • This association requires investigation in African populations.
  • Left ventricular hypertrophy (LVH) is a key indicator of cardiac damage.

Purpose of the Study:

  • To investigate the association between LVH and MetS risk markers in Black African men and women.
  • To explore the role of depressive symptoms in this relationship.

Main Methods:

  • Participants were stratified into groups with (D) or without (ND) depressive symptoms.
  • Fasting metabolic syndrome markers, glycated hemoglobin (HbA1c), ambulatory blood pressure (BP), and Cornell product-LVH (CP-LVH) via ECG were measured.
  • Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria were used for depression assessment.

Main Results:

  • Depressive symptoms were present in 45.3% of the sample.
  • A pre-diabetic state (HbA1c >5.7%) was observed in both men and women, irrespective of depression status.
  • In depressed African women, CP-LVH correlated with lower high-density lipoprotein cholesterol.
  • In depressed African men, systolic BP and HbA1c explained significant variations in LVH (64% and 31%, respectively).

Conclusions:

  • Depressive symptoms in Black African women are associated with CP-LVH, driven by metabolic factors.
  • In Black African men, LVH is primarily driven by cardiometabolic factors like systolic BP and HbA1c, independent of depressive symptoms.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...